NINA Medical is committed to replace surgeon’s knife with image-guided high-intensity focused ultrasound (HIFU) beam.
Led by experienced team of scientists and entrepreneurs, Nina is developing an affordable device that will increase accessibility of high-level medical care to the public.
In particular, women suffering from symptomatic leiomyoma will have the choice for non-invasive, uterus-preserving treatment.
Live imaging of the HIFU field
NINA Medical’s proprietary technology provides live imaging of the HIFU beam profile, displaying the actual position and shape of the focal point in real-time.
Implementing novel techniques in diagnostic ultrasound, NINA controls and navigates the therapeutic beam inside the body, at intensity below the threshold for thermal damage; therefore, cold navigation is achieved, providing safety and efficiency for (non-MRI) image-guided treatment.
With 600,000 hysterectomy procedures in the US, about 50% of them related to symptomatic leiomyoma (uterine fibroids), the direct annual cost to the American market is estimated in $2.1B
“Most women preferred non-invasive options for treatment… many women expressed a clear desire to keep their uterus”
Shmuel Ben-Ezra, MSc, Founder and CEO
Yoni Hertzberg, PhD, MBA, Founder and CTO
Zohar Gendler, MSc, Chairman of the board